Practice pattern for postoperative management of endometrial cancer in Japan: A survey of the Japanese Gynecologic Oncology Group

Gynecologic Oncology

Volumn 115, Issue 3, 2009, Pages 456-459

  Watanabe, Yoh ^a   Kitagawa, Ryo ^b   Aoki, Daisuke ^c   Takeuchi, Satoshi ^d   Sagae, Satoru ^e   Sakuragi, Noriaki ^f   Yaegashi, Nobuo ^g  

^a KINKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b Sapporo Medical Center   (Japan)

^c KEIO UNIVERSITY   (Japan)

^d IWATE MEDICAL UNIVERSITY   (Japan)

^e Sapporo Railway Hospital   (Japan)

^f HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^g TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Adjuvant therapy; Endometrial cancer; Japanese Gynecologic Oncology Group; Survey

Indexed keywords

CARBOPLATIN; CISPLATIN; CYCLOPHOSPHAMIDE; DOCETAXEL; DOXORUBICIN; EPIRUBICIN; PACLITAXEL;

ARTICLE; CANCER ADJUVANT THERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER INVASION; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; ENDOMETRIUM CANCER; FEMALE; HEALTH SURVEY; HISTOPATHOLOGY; HUMAN; JAPAN; MAJOR CLINICAL STUDY; MEDICAL PRACTICE; POSTOPERATIVE CARE; PRIORITY JOURNAL;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARBOPLATIN; CHEMOTHERAPY, ADJUVANT; ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS; JAPAN; NEOPLASM STAGING; PACLITAXEL; PHYSICIAN'S PRACTICE PATTERNS; POSTOPERATIVE CARE;

EID: 70350569304     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2009.08.016     Document Type: Article

References (14)

1. Watanabe Y., Aoki D., Kitagawa R., Takeuchi S., Sagae S., Sakuragi N., et al. Status of surgical treatment procedures for endometrial cancer in Japan: results of a Japanese Gynecologic Oncology Group Survey. Gynecol. Oncol. 105 (2007) 325-328
2. Japan Society of Gynecologic Oncology. Endometrial Cancer Treatment Guidelines 2006 (http://www.jsgo.gr.jp/09_guideline/guideline/e_taigan.pdf).
3. Lurain J.R. Uterine cancer. In: Berek J.S. (Ed). Novak's gynecology 13th ed (2002), Lippincotto Williams & Wilkins, Philadelphia 1143-1147
4. National Comprehensive Cancer Network. Clinical Practice Guidelines in Oncology V2. 2009 (http://www.nccn.org/professionals/physiciangls/PDF/uterine.pdf).
5. Susumu N., Sagae S., Udagawa Y., Niwa K., Kuramoto H., et al. Randomized phase III trial of pelvic radiotherapy versus cisplatin-based combination chemotherapy in patients with intermediate- and high-risk endometrial cancer: a Japanese Gynecologic Oncology Group study. Gynecol. Oncol. 108 (2008) 226-233
6. Randall M.E., Filiaci V.L., Muss H., Spirtos N.M., Mannel R.S., et al. Randomized phase III trial of whole-abdominal irradiation versus doxorubicin and cisplatin chemotherapy in advanced endometrial carcinoma: a Gynecologic Oncology Group Study. J. Clin. Oncol. 24 (2006) 36-44
7. ASTEC/EN.5 Study Group. Adjuvant external beam radiotherapy in the treatment of endometrial cancer (MRC ASTEC and NCIC CTG EN.5 randomised trials): pooled trial results, systemic review, and meta-analysis. Lancet 373 (2009) 97-99
8. Naumann R.W., and Coleman R.L. The use of adjuvant radiation therapy in early endometrial cancer by members of the Society of Gynecologic Oncologists in 2005. Gynecol. Oncol. 105 (2007) 7-12
9. Humber C.E., Tierney J.F., Symonds R.P., Collingwood M., Kirwan J., Williams C., and Green J.A. Chemotherapy for advanced, recurrent or metastatic endometrial cancer: a systemic review of Cochrane collaboration. Ann. Oncol. 18 (2007) 409-420
10. Fleming G.F., Brunetto V.L., Cella D., Look K.Y., Reid G.C., et al. Phase III trial of doxorubicin plus cisplatin with or without paclitaxel plus filgrastim in advanced endometrial carcinoma: a Gynecologic Oncology Group Study. J. Clin. Oncol. 22 (2004) 2159-2166
11. Fleming G.F. Major progress for a less common cancer. J. Clin. Oncol. 24 (2006) 6-8
12. Maggi R., Lissoni A., Spina F., Melpignano M., Zola P., et al. Adjuvant chemotherapy vs. radiotherapy in high-risk endometrial carcinoma: results of a randomized trial. Br. J. Cancer 95 (2006) 266-271
13. UMIN000000522. JGOG2043: a randomized phase III trial of AP versus DP, TC regimens for high risk group of endometrial carcinoma (http://center.umin.ac.jp:80/cgi-o19n-bin/).
14. Nomura H., Aoki D., Takahashi F., Katsumata N., Watanabe Y., et al. Randomized phase II study comparing docetaxel plus cisplatin, docetaxel plus carboplatin, and paclitaxel plus carboplatin in patients with advanced or recurrent endometrial carcinoma: Japanese Gynecologic Oncology Group trial (JGOG 2041). J. Clin. Oncol. 26 (2008) (May 20 suppl; abstr 16526)